IBDimmunology Profile Banner
Shrinivas Bishu Profile
Shrinivas Bishu

@IBDimmunology

Followers
3K
Following
21K
Media
383
Statuses
12K

IBD Clinical Director & GI APD @UMichGIHep, #BillsMafia, minivan driving husband of @jquigleymd, my daughters think I’m a dweeb, cause I peaked in 1996.

Ann Arbor, MI
Joined September 2019
Don't wanna be here? Send us removal request.
@IBDimmunology
Shrinivas Bishu
12 hours
RT @AshkanRA: 🚨 Scrotal swelling in a patient with Crohn’s disease: More than meets the eye 👀 . Grateful to @JeanFredericCo1 for the mentor….
0
2
0
@IBDimmunology
Shrinivas Bishu
12 hours
RT @EdwardLoftus2: We “knew it” until we didn’t.
0
2
0
@IBDimmunology
Shrinivas Bishu
1 day
RT @ebtapper: Phenomenal people.
0
1
0
@IBDimmunology
Shrinivas Bishu
1 day
RT @UM_IHPI: Congratulations! @UMichPharmacy @umichmedicine.
0
1
0
@IBDimmunology
Shrinivas Bishu
1 day
RT @AmJGastro: The July issue of the #RedJournal is here!. Explore this month's articles, including a new ACG Clinical Guideline: Preventi….
0
12
0
@IBDimmunology
Shrinivas Bishu
1 day
RT @JulsgaardMette: 🤱#Upadacitinib detectable in breast milk(n=40) Relative Infant Dose 2.7% (IQR 0.8-10.6) RID ~ #tofacitinib but ⬆️ than….
0
22
0
@IBDimmunology
Shrinivas Bishu
1 day
RT @Bealoquebea: Highly relevat. Congratulations Mette @JulsgaardMette.
0
3
0
@IBDimmunology
Shrinivas Bishu
1 day
RT @khalili_MD: Great to see this work out. We found no evidence of a causal relationship between most medications and risk of microscopic….
0
3
0
@IBDimmunology
Shrinivas Bishu
1 day
RT @atlantisIBS: Low-dose amitriptyline shows clear superiority over placebo for IBS (61.3% vs 45.1% reported significant improvement). Fun….
0
2
0
@IBDimmunology
Shrinivas Bishu
1 day
RT @nehagastrord: Coming Soon!.
0
2
0
@IBDimmunology
Shrinivas Bishu
1 day
RT @UMichGIHep: July 1st means new friends!. So excited to welcome this awesome group of new #GI fellows to Ann Arbor!. #GoBlue 〽️ https://….
0
2
0
@IBDimmunology
Shrinivas Bishu
1 day
RT @halesj126: Happy (Belated) July 1st to those who celebrate!.
0
2
0
@IBDimmunology
Shrinivas Bishu
2 days
RT @alex_ford12399: Our latest paper examining the prevalence of symptoms of anxiety or depression in people with #IBD at diagnosis is now….
0
13
0
@IBDimmunology
Shrinivas Bishu
2 days
RT @jalpa_devi: 🎓 After 2 transformative years of IBD fellowship @WashUMedIBD with incredible mentors @CiorbaGI & @P_DeepakIBDMD.📍 Now star….
0
7
0
@IBDimmunology
Shrinivas Bishu
3 days
RT @halesj126: Look at those @UMichGIHep stars! 🤩.
0
2
0
@IBDimmunology
Shrinivas Bishu
3 days
RT @EdBarnesMD: @GKochharMD @ibdtweets I think this is a version of the slide @GKochharMD mentioned. This from our recent publication in @A….
0
2
0
@IBDimmunology
Shrinivas Bishu
3 days
RT @EdBarnesMD: @ibdtweets For surveillance pouchoscopy for high risk patients, I think there is definitely an approach/opportunity for ris….
0
2
0
@IBDimmunology
Shrinivas Bishu
3 days
RT @GKochharMD: Yes it can be personalized @EdBarnesMD has a very nice slide on personalizing surveillance. In regard to reusing biological….
0
1
0
@IBDimmunology
Shrinivas Bishu
3 days
0
3
0